These mutated genes are not typically found in AML or MDS, and their clinical implications are commonly denoted as having “uncertain significance.” Nevertheless, as a clonal marker, it can serve as a surrogate indicator for JAK2, CALR, or MPL mutations, which is one of the major criteria for ET and PMF.[16]. This evidence concerns the gene CALR and acute myeloid leukemia.